Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis (YES-IPF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02848625|
Recruitment Status : Unknown
Verified July 2016 by Bridget Collins, University of Washington.
Recruitment status was: Not yet recruiting
First Posted : July 28, 2016
Last Update Posted : July 28, 2016
|Condition or disease||Intervention/treatment||Phase|
|Idiopathic Pulmonary Fibrosis||Other: Yoga||Not Applicable|
Idiopathic Pulmonary Fibrosis (IPF) is a chronic progressive fibrotic (scarring) disease of the lung of unknown cause. Approximately 100,000 Americans will die from IPF this year. There is no cure for IPF other than lung transplantation, which only 1% of patients will receive. Recently, 2 drugs were approved by the FDA to slow the rate of decline in lung function among patients with IPF. These drugs do not decrease symptoms or improve quality of life.
Symptoms of IPF include shortness of breath, cough, and fatigue, all of which may also adversely affect quality of life. Yoga is a practice of exercises, including breathing exercises, that has been shown to be relatively safe and to improve quality of life in some patients with other advanced lung diseases. We hypothesize that regular yoga and breathing exercises, specifically designed for patients with Idiopathic Pulmonary Fibrosis, over a period of 12 weeks will lead to improved quality of life as measured by several different quality of life questionnaires.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||64 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis|
|Study Start Date :||August 2016|
|Estimated Primary Completion Date :||April 2018|
|Estimated Study Completion Date :||April 2018|
Experimental: Group A
Patients randomized to 12 weeks of twice weekly yoga sessions. The yoga exercises have been designed specifically for patients with IPF.
Yoga and breathing exercises designed for patients with IPF. Sessions will be two times per week for 12 weeks
No Intervention: Group B
Patients who are not randomized to yoga sessions will continue with their usual care and usual activities
- Quality of life [ Time Frame: 12 weeks ]
- change in forced vital capacity [ Time Frame: 12 weeks ]
- change in 6 minute walk distance [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02848625
|Contact: Ganesh Raghu, MDemail@example.com|
|Contact: Bridget Collins, MDfirstname.lastname@example.org|
|Principal Investigator:||Ganesh Raghu, MD||University of Washington, Center for Interstitial Lung Diseases|
|Principal Investigator:||Bridget F Collins, MD||University of Washington, Center for Interstitial Lung Diseases|